Edwards Lifesciences (EW) Other Non-Current Assets (2009 - 2026)
Edwards Lifesciences (EW) posted quarterly Other Non-Current Assets of $738.9 million for Q1 2026, down 0.51% year-over-year from $742.7 million in Q1 2025, and up 1.19% quarter-over-quarter from $730.2 million in Q4 2025.
Edwards Lifesciences (EW) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Edwards Lifesciences' Other Non-Current Assets history runs 18 years deep, the most recent figure standing at $738.9 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 0.51% year-over-year to $738.9 million; the TTM figure through Mar 2026 stood at $738.9 million (down 0.51% YoY), while the FY2025 annual figure was $730.2 million, up 6661.11% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $738.9 million, up from $730.2 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $789.8 million in Q2 2024, with the low at $10.8 million in Q4 2024.
- The 5-year median for Other Non-Current Assets is $412.1 million (2023), against an average of $422.0 million.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets slumped 97.67% in 2024, then soared 6661.11% in 2025.
- Edwards Lifesciences' Other Non-Current Assets stood at $299.1 million in 2022, then surged by 54.86% to $463.2 million in 2023, then plunged by 97.67% to $10.8 million in 2024, then jumped by 6661.11% to $730.2 million in 2025, then increased by 1.19% to $738.9 million in 2026.
- Business Quant data shows EW's Other Non-Current Assets at $738.9 million in Q1 2026, $730.2 million in Q4 2025, and $34.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Zimmer Biomet Holdings | 19.32 Bn | 18.91 Bn | 1.54 Bn | 1.08 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 616.40 Mn |
| Mar 31, 2026 | 738.90 Mn |
| Dec 31, 2025 | 730.20 Mn |
| Sep 30, 2025 | 34.60 Mn |
| Jun 30, 2025 | 743.00 Mn |
| Mar 31, 2025 | 742.70 Mn |
| Dec 31, 2024 | 10.80 Mn |
| Sep 30, 2024 | 20.00 Mn |
| Jun 30, 2024 | 789.80 Mn |
| Mar 31, 2024 | 767.60 Mn |
| Dec 31, 2023 | 463.20 Mn |
| Sep 30, 2023 | 447.40 Mn |
| Jun 30, 2023 | 412.10 Mn |
| Mar 31, 2023 | 293.60 Mn |
| Dec 31, 2022 | 299.10 Mn |
| Sep 30, 2022 | 316.50 Mn |
| Jun 30, 2022 | 234.70 Mn |
| Mar 31, 2022 | 129.40 Mn |
| Dec 31, 2021 | 110.80 Mn |
| Sep 30, 2021 | 133.70 Mn |